KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Current Assets (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Current Assets for 11 consecutive years, with $550.5 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 55.69% to $550.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $550.5 million through Dec 2025, up 55.69% year-over-year, with the annual reading at $550.5 million for FY2025, 55.69% up from the prior year.
  • Current Assets hit $550.5 million in Q4 2025 for Fulgent Genetics, up from $507.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $765.3 million in Q1 2022 to a low of $326.5 million in Q3 2024.
  • Historically, Current Assets has averaged $538.1 million across 5 years, with a median of $550.2 million in 2023.
  • Biggest five-year swings in Current Assets: soared 1680.26% in 2021 and later plummeted 40.61% in 2024.
  • Year by year, Current Assets stood at $612.0 million in 2021, then rose by 2.6% to $627.9 million in 2022, then fell by 19.12% to $507.8 million in 2023, then crashed by 30.38% to $353.6 million in 2024, then skyrocketed by 55.69% to $550.5 million in 2025.
  • Business Quant data shows Current Assets for FLGT at $550.5 million in Q4 2025, $507.4 million in Q3 2025, and $428.7 million in Q2 2025.